Anthony Qu

Aug 29, 2024 | pharmaceuticalonline.com | Brian Ball |Nikka Densok USA |Anthony Qu

What Do You Need To Know About AI Readiness? Unlock the full potential of AI and digital solutions with these practical steps to begin moving your biopharma organization's goals forward with optimized data usage. 6 Reasons To Consider HVLD Vs. Vacuum Decay For Pharma ProductsHere, two of the more common methods for container closure integrity testing, high voltage leak detection (HVLD) and vacuum decay, are compared.

Jun 14, 2024 | outsourcedpharma.com | Louis Garguilo |Anthony Qu |Jenny Minigh

With over 35 years’ experience in the medtech, diagnostics, and pharmaceutical markets, SMC Ltd. provides in-house engineering, injection molding, assembly, fill finish, device manufacturing, packaging services, and can manage sterilization. Our customers rely on us for speed-to-market and our program management process is a key to well managed projects. With inhouse global supply chain expertise, we help customers reduce risk while maintaining tight timeframes.

Feb 3, 2024 | drugdeliveryleader.com | Anthony Qu

By Anthony Qu, VP of Research & Development, Adare Pharma Solutions An R&D project has shown that the solubility and dissolution characteristics for Itraconazole can be improved by helping them to maintain an amorphous state after spray drying with selected hydrophillic polymers. This paper explores the concept of converting a crystalline drug into amorphous spray dried dispersion (SDD) to increase the dissolution rates relative to crystalline form.

Jan 17, 2024 | outsourcedpharma.com | Louis Garguilo |Kate Coleman |Anthony Qu

The year 2023, among other potential designations, was the year of oligonucleotides. Accordingly, here’s a question I raised with professionals throughout the year: How do you successfully outsource development and manufacture of an oligo program? Your 6 Priority Areas For A Successful 2024As pharma/biotech companies finesse their road maps for 2024, this article assesses the six priorities vying for attention.

Mar 13, 2023 | pharmaceuticalonline.com | Anthony Qu

By Anthony Qu, VP of Research & Development, Adare Pharma Solutions An R&D project has shown that the solubility and dissolution characteristics for Itraconazole can be improved by helping them to maintain an amorphous state after spray drying with selected hydrophillic polymers. This paper explores the concept of converting a crystalline drug into amorphous spray dried dispersion (SDD) to increase the dissolution rates relative to crystalline form.